EUVIMEDEUVIMED entdecken
Crossref

Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR‐1 Agonists

Mariya A Elkina iD, Mikhail V Khvostov, Sergey O Kuranov, Olga A Luzina iD, Natalia A Zhukova, Yulia V Meshkova, Tatiana G Tolstikova, Nariman F Salakhutdinov

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Mariya A Elkina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Novosibirsk State University, Novosibirsk, Russia. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Receptors, G-Protein-Coupled, Analgesics, Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is considered the “pandemic of the 21st century.” It is a complex multifactorial disease associated with chronic hyperglycemia, causing further complications that result in disability and early mortality. Due to the fact that the main focus of T2DM therapy is to reduce the patient's blood sugar levels, avoiding drug‐induced hypoglycemia is important. Free fatty acid receptor 1 (FFAR1) agonists are considered promising hypoglycemic agents without the risk of hypoglycemia. In the future, FFAR1 agonists may expand the range of safer hypoglycemic agents with a mechanism of action not currently used in T2DM therapy. In this study, the hypoglycemic effect of a novel and potent FFAR1 agonist based on benzyloxyphenylpropanoic acid's core containing an aminobornyl fragment was investigated in a long‐term experiment on C57BL/6 Ay/a (Agouti Yellow) mice. The results demonstrated a reduction in insulin resistance, attributed to the hepatoprotective effect of the compound. Additionally, the analgesic effect of the compound was evaluated in experimental pain models. It appeared that the compound exhibited a moderate analgesic effect at high doses. Furthermore, the FFAR1‐mediated mechanism of action was confirmed through experiments with an FFAR1 antagonist coadministration, which suppressed both hypoglycemic and analgesic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsReceptors, G-Protein-CoupledAnalgesicsPainPhenylpropionatesAnimalsMiceMice, Inbred C57BLMaleStructure-Activity RelationshipDose-Response Relationship, DrugBlood GlucoseMolecular StructureDiabetes Mellitus, Type 2Insulin ResistanceDisease Models, Animal

Stichwörter der Autor:innen

FFAR1 agonistshypoglycemic agentsphenylpropanoic acidterpenoidstype 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsReceptors, G-Protein-CoupledAnalgesicsFfar1 protein, mouseBlood GlucosePhenylpropionates

Autor:innen und Institutionen

  • Novosibirsk State University, Novosibirsk, Russia.
  • N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia.

ORCID-Profile: Mariya A Elkina, Olga A Luzina

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Elkina, M. A., Khvostov, M. V., Kuranov, S. O., Luzina, O. A., Zhukova, N. A., Meshkova, Y. V., Tolstikova, T. G., & Salakhutdinov, N. F. (2025). Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR‐1 Agonists. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70152

Vancouver

Elkina MA, Khvostov MV, Kuranov SO, Luzina OA, Zhukova NA, Meshkova YV, et al. Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR‐1 Agonists. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70152

BibTeX
@article{Elkina2025,
  author = {Elkina, Mariya A and Khvostov, Mikhail V and Kuranov, Sergey O and Luzina, Olga A and Zhukova, Natalia A and Meshkova, Yulia V and Tolstikova, Tatiana G and Salakhutdinov, Nariman F},
  title = {Hypoglycemic and Analgesic Effects of Benzyloxyphenylpropanoic Derivatives of Isobornylamine as FFAR‐1 Agonists},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70152}
}
Kostenlos starten →